HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Givenchy adorning Organza February launch with $10 mil. ad/promo campaign.

This article was originally published in The Rose Sheet

Executive Summary

GIVENCHY DRESSING UP ORGANZA WOMEN's SCENT FOR U.S. LAUNCH in February. The LVMH subsidiary's ninth women's fragrance will bow in "very exclusive" distribution of "under 100" doors, including Saks Fifth Avenue and Neiman Marcus, the company said. Expansion to "several hundred undetermined major accounts" will occur by Mother's Day and a rollout to Givenchy's full distribution of 1,800 doors will begin in September.

You may also be interested in...



Marketing In Brief

Nars: Flirtatious Fantasy collection inspired by the sea will debut next month at Barneys New York, Bergdorf Goodman, Saks, Neiman Marcus and Sephora, firm says. "Bursting with fresh, ripe colors reminiscent of rich blue tropical waters and coral sunsets," range includes duo eyeshadows in Island Fever and Dream Lover for $28 and single eyeshadows ($18) in Fathom, Heart of Glass, Parrot Cay and Roxbury. Nars also is introducing lip glosses in Frisky Summer and Turkish Delight ($20)...

OCA Applauds Organic Board's Recommendation To USDA: "Outlaw Nanotech"

With a push from the Organic Consumers Association, the National Organic Standards Board is recommending that the use of nanotechnology be strictly prohibited from products certified under the National Organic Program

Latest Headlines
See All
UsernamePublicRestriction

Register

RS003391

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel